Clinical Trials Directory

Trials / Completed

CompletedNCT01915368

Determining Optimal Post-Stroke Exercise (DOSE)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
75 (actual)
Sponsor
University of British Columbia · Academic / Other
Sex
All
Age
19 Years
Healthy volunteers
Not accepted

Summary

The investigators will conduct a proof-of-concept study to provide preliminary evidence of efficacy of physical exercise dose on ambulatory function in adults undergoing sub-acute stroke rehabilitation.

Detailed description

Participants admitted for stroke rehabilitation will be randomly assigned to either the Stroke Management Group, Stroke Monitoring Group or Stroke Supplementary Group. All three groups will receive usual care, in addition to the intervention. The Stroke Management Group will be provided with periodic information about their progress in the area of mobility using specialized activity monitors. The Stroke Monitoring Group will be progressed according to customized protocols using feedback from specialized activity monitors. The Stroke Supplementary Group will receive the same as the Stroke Monitoring Group, but will also receive one additional hour of daily (5 times per week) physical exercise

Conditions

Interventions

TypeNameDescription
BEHAVIORALStroke Management Program (SMP)Participants will have usual care, and in addition, be provided with periodic information about their progress in the area of mobility using specialized activity monitors
BEHAVIORALStroke Monitoring Program (SMonP)Participants will have usual care, and in addition, be progressed according to customized protocols using feedback from specialized activity monitors
BEHAVIORALStroke Supplementary Program (SSP)Participants will have usual care, and in addition, will receive the same as the Stroke Monitoring Group, and also receive one additional hour of daily (5 times per week) physical exercise

Timeline

Start date
2013-09-01
Primary completion
2019-12-01
Completion
2019-12-01
First posted
2013-08-02
Last updated
2019-12-16

Locations

8 sites across 1 country: Canada

Source: ClinicalTrials.gov record NCT01915368. Inclusion in this directory is not an endorsement.